♢ At the end of a title indicates that the FDA has not cleared prescription drugs, approved medical devices and/or biologics for the use described in this presentation. The prescription drugs, approved medical devices and/or biologics are being discussed for an off-label use.

Browse All

Current Filters

CLEAR FILTER x

TITLE

e0121 Racial and Ethnic Disparities in Perceived Health and Barriers to Care Among Adults with Hip Osteoarthritis: A National Analysis of 16,000+ Patients from the All of Us Program

Author:Ahmed Emara, MD  Shujaa Khan  smitt brahmbhatt  Khaled Elmenawi, MD  Carlos Higuera Rueda, MD, FAAOS  Michael Bloomfield, MD, FAAOS  Robert Molloy, MD  Matthew Deren, MD, FAAOS  Nicolas Piuzzi, MD  

Event Title:ePosters  

Event Type:ePosters  

Category-Classification:Adult Reconstruction Hip  

Event Day:Monday, March 2  

e0209 Step Counts Decline to ~3,700 at 30 Days but Return to Baseline (~5,300) by 6 Months Post-TKA: A National Wearable Study

Author:Shujaa Khan  smitt brahmbhatt  Khaled Elmenawi, MD  Ignacio Pasqualini, MD  Robert Molloy, MD  Matthew Deren, MD, FAAOS  Viktor Erik Krebs, MD, FAAOS  Nicolas Piuzzi, MD  

Event Title:ePosters  

Event Type:ePosters  

Category-Classification:Adult Reconstruction Knee  

Event Day:Monday, March 2  

PP46 Step Counts Decline to ~3,700 at 30 Days but Return to Baseline (~5,300) by 6 Months Post-TKA: A National Wearable Study

Author:Shujaa Khan  smitt brahmbhatt  Khaled Elmenawi, MD  Ignacio Pasqualini, MD  Robert Molloy, MD  Matthew Deren, MD, FAAOS  Viktor Erik Krebs, MD, FAAOS  Nicolas Piuzzi, MD  

Event Title:Poster  

Event Type:Posters  

Category-Classification:Adult Reconstruction Knee  

Event Day:Wednesday, March 4